Triple

T15614042
Position Surface form Disambiguated ID Type / Status
Subject United States federal drug laws E375367 entity
Predicate enforcedBy P1115 FINISHED
Object United States Food and Drug Administration E13297 NE FINISHED

How this triple was built (2 steps)

Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.

NER Named-entity recognition gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: United States Food and Drug Administration | Statement: [United States federal drug laws, enforcedBy, United States Food and Drug Administration]
NED1 Entity disambiguation (via context triple) gpt-5-mini-2025-08-07 
Target entity: United States Food and Drug Administration
Context triple: [United States federal drug laws, enforcedBy, United States Food and Drug Administration]
  • A. Food and Drug Administration chosen
    The Food and Drug Administration is a U.S. federal agency responsible for protecting public health by regulating food, drugs, medical devices, and other consumer products.
  • B. Center for Biologics Evaluation and Research
    The Center for Biologics Evaluation and Research is the U.S. regulatory body responsible for overseeing the safety, efficacy, and quality of biological products such as vaccines, blood products, and gene therapies.
  • C. Center for Drug Evaluation and Research
    The Center for Drug Evaluation and Research is the U.S. FDA division responsible for overseeing the safety, effectiveness, and quality of prescription and over-the-counter drugs.
  • D. Office of Regulatory Affairs
    The Office of Regulatory Affairs is the U.S. FDA’s primary field organization responsible for inspecting regulated products and manufacturers, enforcing compliance, and overseeing import operations to protect public health.
  • E. U.S. Food and Drug Administration Office of the Commissioner
    The U.S. Food and Drug Administration Office of the Commissioner is the central executive office that provides overall leadership, policy direction, and oversight for all FDA regulatory and public health activities.
  • F. None of above.
  • G. Unsure - the case is ambiguous/there is not enough information to decide.

Provenance (3 batches)

The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.

Step Stage Batch ID Status When
creating Elicitation batch_69d85ccf2794819096cda4cbcb02d478 completed April 10, 2026, 2:13 a.m.
NER Named-entity recognition batch_69e04e83407c8190abbcd4b7fab0ff85 completed April 16, 2026, 2:50 a.m.
NED1 Entity disambiguation (via context triple) batch_69ff56d91f208190a11f0d208970145b completed May 9, 2026, 3:46 p.m.
Created at: April 10, 2026, 4:13 a.m.